CBD Med Research Corp. (TSXV:CBMH) (the “Company”) announces that the Company will change its name to World Class Extractions Inc. and subdivide its common shares on the basis of three new common shares for every one existing common share (the “Share Split”), effective as of February 28, 2019 (the “Effective Date”).
Registered shareholders of the Company will receive two additional common shares for each common share held as of February 27, 2019 (the “Record Date”). The Company’s transfer agent, Computershare Investor Services Inc. (“Computershare”), will send to each registered shareholder a share certificate representing the number of additional common shares that they are to receive as a result of the Share Split. Non-registered shareholders who hold their shares through an intermediary will have their accounts automatically updated to reflect the Share Split.
Immediately prior to completion of the Share Split, the Company has 9,671,525 common shares issued and outstanding. After giving effect to the Share Split, the Company will have approximately 29,014,575 common shares issued and outstanding.
Further to the Company’s news release dated February 21, 2019, the Company’s common shares will be delisted from trading on the TSX Venture Exchange effective at the close of trading on February 26, 2019 in connection with the proposed reverse take-over transaction of the Company (the “Proposed Transaction”). The resulting issuer that will exist upon completion of the Proposed Transaction intends to apply to the Canadian Securities Exchange (“CSE”) for approval for listing its common shares on the CSE.
ON BEHALF OF THE BOARD OF DIRECTORS
“Gary F Zak”
Gary F. Zak, Chief Executive Officer
For further information, please contact: Gary F. Zak firstname.lastname@example.org or 604-802-7551
Neither the TSX Venture Exchange nor its Regulation Services Provider (as such term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
The CSE has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved the contents of this news release.
This news release contains certain forward-looking information and forward-looking statements within the meaning of applicable securities legislation (collectively “forward-looking statements”). The use of any of the word, “may”, “will”, “proposes”, “expects”, “anticipates”, “intends” and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Such forward-looking statements should not be unduly relied upon. This news release contains forward-looking statements and assumptions pertaining to the following: the name change of the Company, the Share Split, delisting the Company’s common shares from the TSXV, listing the Company’s common shares on the CSE, and the Proposed Transaction. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors. The Company believes the expectations reflected in those forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).
Canopy Growth to Participate in BofA Securities Virtual Consumer & Retail Technology Conference on March 11, 2021
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) (“Canopy Growth” or “the Corporation”) announced today that EVP & CFO Mike Lee will be participating in a fireside chat at the BofA Securities Virtual Consumer & Retail Technology Conference on Thursday, March 11, 2021 at 9:30am ET .
Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”). The Company announces that further to its press release dated March 2, 2021, it has obtained TSX Venture Exchange approval to extend the closing date of its previously announced private placement of units (“Units”) until April 7, 2021. Each Unit is comprised of one (1) common share and one (1) warrant, exercisable for one common share at price of $0.11 per share, for a period of three (3) years from the date of Closing. The Company applied to extend the date of closing to allow a greater number of interested investors to participate.
For more information regarding the Company or the offering, please contact email@example.com, or